Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

NCT03217747 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

173

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Castration-Resistant Prostate Carcinoma
Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Metastatic Prostate Carcinoma
Prostate Carcinoma Metastatic in the Bone
Refractory Malignant Solid Neoplasm
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG: Avelumab
BIOLOGICAL: Ivuxolimab
RADIATION: Radiation Therapy
BIOLOGICAL: Utomilumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]